hyaluronic acid sodium salt
DeviceTwo injections of 2 % (40 milligrams (mg) / 2 millilitres (ml)) hyaluronan in weekly interval.
NCT Number: NCT01290510
The primary objective of this study is to evaluate the efficacy and safety of TCHY106 (2% hyaluronan) in the treatment of painful tendinopathy.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Zentrum für Orthopädie und Sportmedizin München, Munich, Bavaria, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two injections of 2 % (40 milligrams (mg) / 2 millilitres (ml)) hyaluronan in weekly interval.
Time frame: Baseline and Day 35
Time frame: On Day 7
Time frame: On Day 90
Time frame: At baseline
Measured by 5-point scale, ranking from 'none' to 'extreme' intensity.
Time frame: On Day 7
Measured by 5-point scale, ranking from 'none' to 'extreme' intensity.
Time frame: On Day 35
Measured by 5-point scale, ranking from 'none' to 'extreme' intensity.
Time frame: On Day 90
Measured by 5-point scale, ranking from 'none' to 'extreme' intensity.
Time frame: At baseline
Time frame: On Day 7
Time frame: On Day 35
Time frame: On Day 90
Time frame: On Day 7
Measured by Clinical Global Impression (CGI) 7-point scale, ranking from 'very much improved' to 'very much worse' condition
Time frame: On Day 35
Measured by Clinical Global Impression (CGI) 7-point scale, ranking from 'very much improved' to 'very much worse' condition
Time frame: On Day 90
Measured by Clinical Global Impression (CGI) 7-point scale, ranking from 'very much improved' to 'very much worse' condition
Time frame: Up to Day 90
TRB Chemedica AG
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03287596
Arthritis, Bone Diseases
Bordeaux, France
View Trial DetailsNCT07261449
Muscular Diseases, Musculoskeletal Diseases
Salamanca, Spain
View Trial DetailsNCT05569174
Muscular Diseases, Musculoskeletal Diseases
Karlsruhe, Baden-Wurttemberg, Germany
View Trial DetailsNCT04753853
Muscular Diseases, Musculoskeletal Diseases
Bologna, Italy
View Trial Details